Viewbix Inc. announces acquisition of Quantum X Labs, enhancing its position in the quantum technology sector.
Quiver AI Summary
Viewbix Inc. has announced its agreement to acquire a substantial stake in Quantum X Labs Ltd., a leading quantum technology lab in Israel. The acquisition, which will secure between 85% and 100% ownership, aims to enhance Viewbix's capabilities in the rapidly evolving quantum technology sector, with the deal expected to finalize in the coming months, following regulatory approvals and stockholder consent. Quantum X Labs is recognized for its interdisciplinary approach to quantum technologies, focusing on innovations such as quantum navigation systems, error correction for quantum computing, and advancements in quantum-based security. This strategic move positions Viewbix to leverage Quantum X Labs' extensive intellectual property and expertise as the demand for quantum solutions in areas like personalized medicine and secure communications grows. The acquisition underscores Viewbix's commitment to accelerating commercialization in the quantum arena, with significant potential to transform various industries.
Potential Positives
- Viewbix is acquiring a significant stake (up to 100%, but not less than 85%) in Quantum X Labs, positioning itself as a major player in the advancing quantum technology sector.
- The acquisition integrates Quantum X Labs’ patented innovations and interdisciplinary expertise, enhancing Viewbix’s capabilities in high-impact commercial applications of quantum technologies.
- Quantum X Labs’ existing portfolio companies address critical challenges in various fields, such as navigation and security, which aligns with Viewbix’s growth strategy in emerging markets.
- The timing of the acquisition aligns with the anticipated growth in sectors like personalized medicine and secure communications, potentially offering substantial value and market opportunity for Viewbix.
Potential Negatives
- The acquisition is subject to regulatory approvals, stockholder consent, and customary conditions, which introduces uncertainty regarding the completion timeline and could delay operational integration.
- The reliance on forward-looking statements emphasizes the potential for significant risks and uncertainties, which may concern investors about the feasibility and success of the acquisition.
- Viewbix's main business operations in digital advertising may overshadow its capability to effectively integrate and manage a high-tech entity like Quantum X Labs, raising questions about resource allocation and strategic focus.
FAQ
What is Viewbix's latest acquisition announcement?
Viewbix announced a definitive agreement to acquire up to 100% of Quantum X Labs, focusing on quantum technology innovations.
How will the acquisition benefit Viewbix?
The acquisition aims to enhance Viewbix's position in the growing quantum sector by integrating advanced technologies and IP from Quantum X Labs.
What is Quantum X Labs known for?
Quantum X Labs is recognized for its interdisciplinary approach, developing solutions in quantum navigation, error correction, and security among others.
When is the expected closing date for the acquisition?
The acquisition is expected to close within 90 days from December 15, 2025, pending regulatory approvals and stockholder consent.
What markets could benefit from Quantum X Labs' innovations?
Potential markets include personalized medicine and secure communications, projected to grow significantly as quantum technologies mature.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$VBIX Insider Trading Activity
$VBIX insiders have traded $VBIX stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $VBIX stock by insiders over the last 6 months:
- ELIYAHU YORESH has made 2 purchases buying 265,144 shares for an estimated $284,999 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$VBIX Hedge Fund Activity
We have seen 3 institutional investors add shares of $VBIX stock to their portfolio, and 1 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- YORKVILLE ADVISORS GLOBAL, LP added 346,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $1,207,540
- XTX TOPCO LTD added 16,212 shares (+inf%) to their portfolio in Q3 2025, for an estimated $56,579
- UBS GROUP AG added 104 shares (+inf%) to their portfolio in Q3 2025, for an estimated $362
- MORGAN STANLEY removed 17 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $59
- MMCAP INTERNATIONAL INC. SPC added 0 shares (+0.0%) to their portfolio in Q3 2025, for an estimated $0
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
Tel Aviv, Israel, Jan. 02, 2026 (GLOBE NEWSWIRE) -- In a move poised to reshape the landscape of advanced technologies, Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), has solidified its commitment to quantum innovation by signing a definitive agreement to acquire up to 100%, but not less than 85%, of Quantum X Labs Ltd., Israel's multi-disciplinary quantum technology laboratory. This strategic acquisition, announced in mid-December 2025 and expected to close within the next few months, comes at a pivotal moment as quantum technologies transition from lab curiosities to high-impact commercial solutions. The potential acquisition provides deeper insight into Quantum X Labs' innovations, highlighting potential in the growing quantum sector.
Founded on the vision that quantum progress thrives through interdisciplinary convergence, Quantum X Labs has built a unique ecosystem uniting top-tier talent and cutting-edge research. Drawing from Israel's renowned academic powerhouses- including the Hebrew University of Jerusalem, Tel Aviv University, the Technion, and the Weizmann Institute—Quantum X Labs employs a multidisciplinary team of scientists, engineers, and researchers. This blend of theoretical expertise and practical engineering has enabled rapid translation of ideas into deployable technologies, positioning Quantum X Labs as a cornerstone of Israel's quantum sector and a rising player globally.
At the heart of Quantum X Labs' operations are five portfolio companies, each tackling a distinct quantum challenge:
- Quantum Navigation : Developing reliable systems for GPS-denied environments, essential for defense, autonomous vehicles, and remote operations.
- Quantum Error Correction : Addressing scalability issues in quantum computing with patented solutions that reduce computational overhead by up to 50% compared to traditional methods.
- Quantum Algorithmic Platforms : Focused on clinical and biomedical research, including a recent provisional patent for quantum-enhanced Markov Chain Monte Carlo methods that could revolutionize drug discovery by uncovering hidden biological structures in trial data.
- Next-Generation Atomic Clocks : Leveraging quantum principles for unprecedented precision in timing and synchronization applications.
-
Quantum-Based Security
: Protecting data, communications, and critical infrastructure against emerging threats.
This diversified approach not only mitigates risks but amplifies synergies, allowing advancements in one area to bolster others. For instance, Quantum X Labs's quantum error correction patent, sub-licensed in collaboration with Ramot (Tel Aviv University's technology transfer arm), supports fault-tolerant computing essential for all portfolio initiatives. Quantum X Labs has already demonstrated its international stature by participating in the world's largest quantum conference in Denmark last November, showcasing Israel's contributions to global innovation.
Viewbix believes that the timing of its potential acquisition couldn't be more opportune. As quantum computing matures, markets like personalized medicine and secure communications are projected to explode, with Quantum X Labs' IP portfolio- including multiple upcoming patent filings- poised to capture significant value.
For those eyeing the quantum boom, this potential acquisition highlights Quantum X Labs' strong foundation: a patented portfolio, elite talent, and a clear path to commercialization. As the deal progresses- subject to regulatory approvals, stockholder consent, and customary conditions-expect further milestones that could transform industries.
Viewbix recently signed a definitive agreement to acquire up to 100% (and not less than 85%) of Quantum X Labs, encompassing its expanding patent portfolio, including prior IP in quantum error correction. The acquisition is expected to close within 90 days of the date of execution of the definitive agreement, which was December 15, 2025, subject to final due diligence, regulatory approvals, the approval of the Company’s stockholders in accordance with applicable rules or regulations of the Nasdaq Stock Market LLC and customary closing conditions.
About Viewbix Inc.
Viewbix, through certain of its subsidiaries Gix Media Ltd. and Metagramm Software Ltd., operates in the field of digital advertising. Gix Media develops a variety of technological software solutions, which perform automation, optimization and monetization of internet campaigns, for the purposes of acquiring and routing internet user traffic to its customers. Metagramm is a developer of grammatical error correction software. The company offers tools for writing and reviewing, grammar, spelling, punctuation and style features, as well as translation and multilingual dictionaries, using artificial intelligence and machine learning technology.
Viewbix’s technological tools allow advertisers and website owners to earn more from their advertising campaigns and generate additional profits from their websites.
For more information about Viewbix, visit https://view-bix.com/
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses the timing and completion of the acquisition, the receipt of regulatory approvals, the receipt of approval by the Company’s stockholders and the satisfaction of closing conditions related to the acquisition. Because such statements deal with future events and are based on Viewbix’s current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements could differ materially from those described in or implied by the statements in this press release.
The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed in any filings with the SEC. Except as otherwise required by law, Viewbix undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Viewbix is not responsible for the contents of third-party websites.
Investor Relations Contacts:
Michal Efraty
Investor Relations
[email protected]